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Abstract:  Leprosy has been a major burden on humanity over thousands of years. Perhaps no other 
disease in the history of mankind has been associated with such a strong social stigma as leprosy. 
Failure in early detection often leads to severe disability in spite of eradication of mycobacteria at a 
later date. Untreated the disease is progressive and results in permanent damage to the skin, nerves, 
limbs and eyes. 
Objectives: To study the pattern of neurological manifestations among adult Sudanese leprosy 
patients seen in Khartoum Dermatology Hospital in the period from March 2006 to August 2006. 
Methodology: This is a prospective cross-sectional hospital-based study. Seventy adult Sudanese 
leprosy patients were studied using simple, direct, standardized questionnaire including history and 
neurological examination, during the period from March to August 2006.
Results: The most common age group affected was 18- 27 years. Male to female ratio was 3:1. 
Numbness was the most common neurological symptom seen in 77.14%. Each of visual 
disturbance, headache and bilateral ulnar sensory impairment was detected in 7.14%. Half of the 
patients had upper limbs sensory nerve dysfunction while 42.86% exhibited sensory nerve 
dysfunction in the lower limbs. "Gloves and stoking" sensory impairment was the most common 
finding (30%) while bilateral lateral popliteal sensory impairment was seen with the same 
percentage. Bilateral median and unilateral posterior tibial sensory impairment were found in 1.43% 
each. Unilateral radial cutaneous sensory impairment was seen in 2.86%. Approximately half 
(48.57%) of the patients had upper limbs motor dysfunction. Bilateral ulnar distribution motor 
affection was seen in 40%. A significant number (41.43%) had upper limbs muscle wasting. 
Impaired olfaction was the most common cranial nerve sign seen in 12.86%. Leprosy reactions 
were detected in 21.43%; type 2 reaction in 14.29% while type 1 reaction in 7.14%. 
Conclusion: Numbness and limbs weakness were the most common neurological symptoms in 
leprosy patients. Peripheral nerve sensory impairment was found in half of the patients with 
"Gloves and stokes" peripheral sensory neuropathy being the most common sensory disturbance. 
Motor dysfunction was found in 48.57%. Ulnar and median nerves motor affection was the most 
common motor dysfunctions. Signs related to cranial nerves involvement were less common. 
Leprosy reactions were present in one-fifth of the patients. 
Keywords: Mycobacterium leprae, granulomatous, numbness, popliteal. 
 
eprosy is a chronic granulomatous 
infectious disease that has been a 
major burden on human over 
thousands of years. It was recognized in the 
ancient civilizations of China, Egypt and 
India. The earliest report of leprosy dated 
back to 600 BC1.
Abbashar Hussein, Associated Prof Faculty of 
Medicine, department of neurology, University of 
Khartoum, Sudan, P. O. Box 102 Khartoum, Sudan, 
Tel. +2499123456722. E-mail: 
abbashar59@yahoo.com 
Perhaps no other disease in the history of 
mankind has been associated with such a 
strong social stigma as leprosy. In 1873, 
Armauer Hansen isolated the bacterium 
Mycobacterium leprae from the lesions of a 
Norwegian patient, making leprosy the first 
disease for which an infectious agent was 
identified. Failure of early detection often 
leads to severe disability in spite of 
eradication of mycobacterium at a later date. 
The most likely mode of transmission is 
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through nasal secretions and skin contact. The 
disease is thought to be of low infectivity. In 
most populations, over 95% of individuals are 
naturally immune2-3. In spite of this the 
disease accounts for approximately 10 million 
affected people worldwide. Leprosy remained 
an incurable disease until 1940, when the first 
breakthrough occurred with the development 
of dapsone, a drug capable of arresting the 
disease4.Today, it is widely accepted that 
multi-drug therapy (MDT) renders leprosy 
curable.  
Objective: 
To study the pattern of neurological 
manifestations of leprosy among adult 
Sudanese patients seen at Khartoum 
Dermatology Hospital in the period from 
March 2006 to August 2006. 
 
Methods:
This is a descriptive prospective hospital 
based cross sectional study. Those below 18 
years of age were excluded. All patients gave 
their consent to participate in the study. A full 
detailed history and proper systemic and 
neurological  examination  was  performed by  
the authors. The physical signs were grouped 
into general, systemic, dermatological and 
neurological. According to WHO, diagnosis 
of leprosy is clinical and is based on patients 
having one or more of three cardinal signs: 
1- Hypopigmented or reddish patches with 
definite loss of sensation.2- Thickened 
peripheral nerves.3- Acid-fast bacilli on skin 
smears or biopsy material. Investigations 
were needed only in cases where the 
diagnosis was doubtful or where recurrence 
was suspected. The disease is classified into 
paucibacillary (PB) and multibacilary (MB) 
leprosy according to WHO classification. 
Standard regiments of MDT according to 
WHO therapeutic guidelines were used for the 
treatment of the patients included in the study. 
The following drugs were used: 
1- Rifampicin.2- Dapsone.3- Clofazimine. 
Patients with reactions were treated with 
prednisolone in addition to MDT. Data were 
analyzed and discussed. 
 
Results: 
Males constituted 74.29% of the patients. 
22.86% of the patients were at 18-27 years of 
age (Table 1).  
 
Table1: Age and sex distribution. 
 
No. (%)No. (%)No. (%) Age
22 (31.43)6 (8.57)16 (22.86)18- 27 yr
16 (22.86)5 (7.14)11(15.71)28 -37 yr
12 (17.14)3 (4.29)9 (12.86)38- 47 yr
11 (15.71)2 (2.86)9 (12.86)48- 57 yr
5 (7.14)2 (2.86)3 (4.29)58 -67yr
4 (5.71)0 (0.00)4 (5.71)> 68 yr 
70 (100)18(25.71)52(74.29)Total
Geographically 2.86% of the patients were 
from Eastern region,11.43% from Northern 
region,8.57% from Khartoum region, 30% 
from Central region, 18.31% from Kordofan 
region,8.57% from Darfour region,8.57% 
were from Upper Nile region,4.29% from 
Equatorial region and 7.14% were from Bahar 
Elgazal region. Occupational background 
showed that farmers constituted 28.57%, 
house wives 18.57%, students 7.14%, soldiers 
4.29% and other different jobs 41.43%. 
4.29% of our patients had past history of 
leprosy while 10% had family history of 
leprosy. Multibacillary (MB) type of leprosy 
was found in 82.86% while 17.14% had 
paucibacillary (PB). Non-neurological 
manifestations were shown in Fig 1. Nasal 
discharge was seen in 42.86%.  
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Fig1. The other common presenting non-neurological symptoms. 
 
Skin pigmentation was seen in all (100%) of 
the patients. Other skin manifestations 
including macules, plaques, papules, nodules, 
and ulcers were seen in 78.57%, 44.29%, 
14.29%, 12.86% and 5.71% respectively.  
General clinical findings included cataract 
which was detected in 2.86%, perforated nasal 
septum in 2.86%, enlarged nose in 4.29%, 
saddle nose in 2.86%, lionine face in 1.86%, 
testicular atrophy in 2.85%, testicular 
swelling in 1.43% and lower limbs oedema in 
1.43%. Almost 61.43% had no sensory 
impairment over the skin lesions, 12.86% had 
sensory impairment confined to some skin 
lesions and 25.71% had sensory impairment 
over all skin lesions.  
 
The common presenting neurological 
symptoms were shown in Table2. 
 
Impaired smelling was detected in 12.86%; all 
had MB disease. Loss of vision in one eye 
was seen in 4.29%; more than half of them  
(2.86%) had MB disease. Impaired vision of 
one eye in 4.29%; all had MB disease.  
Unilateral LMN facial weakness was detected 
in 5.71%; half of them had MB disease. 
 




5 (7.14) Headache 
0 (0.00) Convulsion 
0 (0.00) Loss of consciousness 
9 (12.86) Smelling disturbance
5 (7.14) Visual disturbance
1 (1.43) Inability to close eye
22 (31.43) UL weakness
8 (11.43) LL weakness
54(77.14) Numbness
9 (12.86) Nerve pain
0 (0.00) Sphincter disturbance 
Upper and lower limbs examinations finding 













Skin pigmentation Nasal discharge Nasal bleeding Fever Joint pain Joint swelling 
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Abbasher Hussein et al.                                                    Neurological deficits in lepromatic patients 
© Sudan JMS Vol. 5, o. 1, Mar 2010 20 
 
Table 3: upper limb findings. 
 
PB No. (%)  MB No (%)Total No. (%) Clinical findings
4 (5.71) 25 ( 35.71)29 (41.43) Wasting
1 (1.43) 7 (10) 8 (11.43) Loss of fingers phalanges
1 (1.43) 6 ( 8.57)7 (10.00) Unilateral true claw
2 ( 2.86) 1 (1.43) 3 (4.29) Bilateral true claw
0 (0.00) 2 (2.86) 2 (2.86) Unilateral ulnar claw
0 (0.00) 1 (1.43) 1 (1.43) Bilateral ulnar claw
0 (0.00) 1 (1.43) 1 (1.43) Simian deformity
0 (0.00) 1 (1.43) 1 (1.43) Ulcers
11    (15.71) 55 (78.57) 66 (94.29) Normal tone
1 (1.43) 3 (4.29) 4 (5.71) Hypotonia
8 (11.43) 28 (40) 36 (51.43) Normal power
0 (0.00) 6 (8.57) 6 (8.57) Unilateral ulnar weakness
4 (5.71) 24 (34.29) 28 (40) Bilateral ulnar weakness
0 (0.00) 2 (2.86) 2 (2.86) Unilateral median weakness
4 (5.71) 10 (14.29) 14 (20) Bilateral median weakness
11  (15.71) 57 (81.43) 68 (97.14) Normal reflexes
1 (1.43) 1 (1.43) 2 (2.86) Hyporeflexia
9 (12.86) 26 (37.14) 35 (50.00) Normal sensation
2 (2.86) 19 (27.14) 21 (30.00) "Gloves" pattern sensory impairment 
0 (0.00) 4 (5.71) 4 (5.71) Unilateral ulnar sensory impairment
Table 4: Nerves of upper limbs. 
Nerve Enlarged Tender 
right great auricular 23 6 
left great auricular  24 6 
right ulnar  66 26 
leftt ulnar  69 27 
right radial cutaneous 57 13 
leftt radial cutaneous  56 14 
right lateral popliteal  63 20 
leftt lateral popliteal  63 19 
right posterior tibial  61 19 
leftt posterior tibial  60 17 
Leprosy reactions were not detected in 
78.57% while 7.14% had type 1 reaction and 
14.29% had type 2 reaction. The common 
symptoms among patients presenting with 
reactions (15 patients) were fever (26.67%), 
nerve pain (60%), erythematous rash 
(86.67%), joint pain (53.33%) and joint 
swelling (13.33%).  
 
Discussion: 
The study showed that males were affected 
more than females this is similar to what was  
 
mentioned worldwide5-7. It appeared that the 
age group 18 - 27 years is the most common  
group affected, this is similar to what was 
reported in the literature. This group being the 
most active sector of the community 
highlights the need for early detection and 
treatment of the disease8-9. The prevalence 
seemed to decrease with age being less 
common (5.71%) in the age group >68 years.  
Geographical distribution showed that 30% of 
our patients were from the central region, 
although the disease was found in all other 
regions. This may be due to easy travel to 
Khartoum rather than giving a real clue to 
distribution of the disease in Sudan. 
Considerable number of patients (28.57%) 
were farmers raising the possibility of 
occupational hazards which is not proven yet 
and needs further scientific verification5.
The vast majority of our patients (95.71%) 
had no past history of similar condition; this 
could be due to the fact that the course of the 
disease is usually prolonged and silent 
without remissions and relapses.  
 
Abbasher Hussein et al.                                                    Neurological deficits in lepromatic patients 
© Sudan JMS Vol. 5, o. 1, Mar 2010 21 
 
Table 5: sensory impairment in upper and lower limbs 
 
PB No(%) MB No(%) Total No(%) Clinical findings
1(1.43) 4(5.71) 5(7.14) Bilateral ulnar sensory impairment
0(0.00) 4(5.71) 4(5.71) Unilateral median sensory impairment
1(1.43) 0(0.00) 1(1.43) Bilateral median sensory impairment
0(0.00) 2(2.86) 2(2.86) Unilateral radial cutaneous sensory impairment
0(0.00) 0(0.00) 0(0.00) Bilateral radial cutaneous sensory impairment
11(15.71) 58(82.86) 69(98.57) Normal coordinaton
0(0.00) 0(0.00) 0(0.00) Impaired coordination
1(1.43) 0(0.00) 1(1.43) Difficult to coordination
0 (0.00) 9 (12.86) 9 (12.86) Wasting
0 (0.00) 1 (1.43) 1 (1.43) Drop feet
0 (0.00) 3 (4.29) 3 (4.29) Deep ulcers
2 (2.86) 3 (4.29) 5 (7.14) Loss of toes phalanges
12 (17.14) 56 (80) 68 (97.14) Normal tone
0 (0.00) 2 (2.86) 2 (2.86) Hypotonia
12 (17.14) 55 (78.57) 67 (95.71) Normal power
0 (0.00) 0 (0.00) 0 (0.00) Unilateral posterior tibial weakness
0 (0.00) 1 (1.43) 1 (1.43) Bilateral posterior tibial weakness
0 (0.00) 1 (1.43) 1 (1.43) Unilateral lateral popliteal weakness
0 (0.00) 2 (2.86) 2 (2.86) Bilateral lateral popliteal weakness
12 (17.14) 48 (68.57) 60 (85.71) Normal reflexes
0 (0.00) 10 (14.29) 10 (14.29) Hyporeflexia
9 (12.86) 31 (44.29) 40 (57.14) Normal sensation
2 (2.86) 19 (27.14) 21 (30.00) "stockes" pattern sensory impairment
0 (0.00) 1 (1.43) 1 (1.43) Unilateral posterior tibial sensory impairment 
1 (1.43) 2 (2.86) 3 (4.29) Bilateral posterior tibial sensory impairment 
0 (0.00) 4 (5.71) 4 (5.71) Unilateral lateral popliteal sensory impairment 
1 (1.43) 3 (4.29) 4 (5.71) Bilateral lateral popliteal sensory impairment 
12 (17.14) 58 (82.86) 70 (100.00) Normal coordination
0 (0.00) 0 (0.00) 0 (0.00) Impaired coordination
Almost 90% of our patients had no family 
history of leprosy, this is similar to a study 
done in Canada and it differs from what was 
mentioned in the literature where the presence 
of family history is increased up to 50% in the 
endemic countries7- 11. We think that family 
history is very important because proximity to 
leprosy patients is an important determinant 
of transmission.  
Up to 82.86% of our patients had MB form of 
the disease similar to distribution in some 
countries (eg. Mexico) but it differs from 
what has been reported in Africa12- 14. The 
common presenting non-neurological 
symptoms were found to be skin pigmentation 
(100%) and nasal discharge (42.86%) similar 
to what was mentioned in the literature and 
this is the classical presentation of leprosy 
particularly MB form15,16.
The pattern of skin manifestations among our 
patients showed that macules (78.57%) and 
plaques (44.29%) were the most common skin 
lesions, this is similar to other reports17, 18.
Considerable number of our patients had no 
sensory impairment over skin lesions 
(61.43%), this may be explained by the fact 
that sensory impairment over skin lesions is 
an uncommon and a late feature of the MB 
form of the disease which dominates our 
patients19,20.
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General examination showed variable signs 
eg. cataract, perforated nasal septum, saddle 
or enlarged nose, testicular atrophy and lower 
limbs swelling; this goes with the fact that 
leprosy is a generalized disease with 
multisystem involvement21-23.
It appeared that numbness 
(77.14%) and weakness of the limbs (31.43%) 
were the most common neurological 
symptoms similar to what was mentioned 
elsewhere24,26. This is because leprosy affects 
peripheral nerves leading to sensory 
disturbance and weakness in addition to 
destruction of bones27, 28. The study showed 
that impaired smelling was detected in 
12.86%, this may be attributed to involvement 
of nasal mucus membranes by the disease29, 
30. Lower motor neuron facial weakness was 
detected in 5.71% but no patient was found to 
have trigeminal nerve involvement which is 
similar to what was reported earlier2, 25, 31.
Impairment or loss of vision was found in 
smaller numbers, similar to what was 
mentioned in the literature32, 33. Blindness in 
our study was found to be less than what was 
mentioned in a study done in Nepal34.
Examination of upper and lower limbs 
revealed that wasting, upper limbs weakness 
and sensory disturbance were found to be the 
commonest signs. In upper limbs, half of our 
patients had sensory nerve dysfunction, and 
approximately half of the patients had motor 
dysfunction." Gloves" pattern of sensory 
impairment (30%) was the most common 
sensory dysfunction, whereas bilateral ulnar 
distribution weakness (40%) followed by 
bilateral median distribution weakness (20%) 
were the most common motor dysfunction. In 
the lower limbs, significant number of 
patients (42.86%) exhibited sensory nerve 
dysfunction, while a minority (4.29%) had 
motor dysfunction. 
" Stokes" pattern of sensory impairment 
(30%) was the most common sensory 
dysfunction detected in the lower limbs, 
whereas lateral popliteal weakness (4.29%) 
was the most common motor dysfunction, this 
distribution of sensory and motor involvement 
is more or less similar to what was mentioned 
by Bogglid et al7. However, it seems that our 
patients were more affected; this can be 
explained by delayed presentation of our 
patients and by the fact that most of our 
patients had MB form of leprosy.  
The common nerves found to be enlarged was 
the ulnar nerve, followed by the lateral 
popliteal and posterior tibial nerves this is 
slightly different from what was mentioned in 
the literature35,36. This finding represents the 
most common presenting sign in leprosy.  
Almost 21.43% of our patients were found to 
have reactions at the time of study which is 
generally in agreement with Andrea K. 
Bogglid et al findings but differed in that type 
2 reaction was found to be more common 
(14.29%) than type 1 reaction (only 
7.14%).34This can be explained by the fact 
that most of our patients had MB form. It 
appeared that reactions commonly presented 
with erythematous rashes, nerve pain, 
arthralgia and fever which is similar to what 
was mentioned in the literature37, 38.
Conclusion: Numbness and limbs weakness 
were the most common neurological 
symptoms in leprosy patients. Peripheral 
nerve sensory impairment was found in half 
of the patients with "Gloves and stokes", 
peripheral sensory neuropathy being the most 
common sensory disturbance. Motor 
dysfunction was found in 48.57%. Ulnar and 
median nerves distribution motor affection 
was the most common motor dysfunctions. 
Signs related to cranial nerves involvement 
were less common. Leprosy reactions were 
present in one-fifth of the patients. 
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